Naltrexone and nalmefene: any meaningful difference? - PubMed (original) (raw)
Comment
Naltrexone and nalmefene: any meaningful difference?
Robert M Swift. Biol Psychiatry. 2013.
No abstract available
Comment on
- Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K, Bladström A, Torup L, Gual A, van den Brink W. Mann K, et al. Biol Psychiatry. 2013 Apr 15;73(8):706-13. doi: 10.1016/j.biopsych.2012.10.020. Epub 2012 Dec 11. Biol Psychiatry. 2013. PMID: 23237314 Clinical Trial.
Similar articles
- Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-analysis - Comment to Naudet.
Soyka M, Friede M, Schnitker J. Soyka M, et al. Pharmacopsychiatry. 2016 Nov;49(6):261-262. doi: 10.1055/s-0042-110494. Epub 2016 Jul 7. Pharmacopsychiatry. 2016. PMID: 27388713 No abstract available. - Nalmefene for alcohol dependence.
[No authors listed] [No authors listed] Harv Ment Health Lett. 2000 Mar;16(9):7. Harv Ment Health Lett. 2000. PMID: 10677202 No abstract available. - Trial watch: Nalmefene reduces alcohol use in phase III trial.
[No authors listed] [No authors listed] Nat Rev Drug Discov. 2011 Aug 1;10(8):566. doi: 10.1038/nrd3518. Nat Rev Drug Discov. 2011. PMID: 21804585 Clinical Trial. No abstract available. - Opioid Receptor Antagonists in the Treatment of Alcoholism.
Serecigni JG. Serecigni JG. Adicciones. 2015 Sep 29;27(3):214-30. Adicciones. 2015. PMID: 26437315 Review. English, Spanish. - Bad medicine: nalmefene in alcohol misuse.
Spence D. Spence D. BMJ. 2014 Feb 14;348:g1531. doi: 10.1136/bmj.g1531. BMJ. 2014. PMID: 24531208 Review. No abstract available.
Cited by
- Advances in the science and treatment of alcohol use disorder.
Witkiewitz K, Litten RZ, Leggio L. Witkiewitz K, et al. Sci Adv. 2019 Sep 25;5(9):eaax4043. doi: 10.1126/sciadv.aax4043. eCollection 2019 Sep. Sci Adv. 2019. PMID: 31579824 Free PMC article. Review. - Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.
Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A. Barrio P, et al. Clin Drug Investig. 2018 Feb;38(2):147-155. doi: 10.1007/s40261-017-0590-4. Clin Drug Investig. 2018. PMID: 29080208 Clinical Trial. - Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options.
Mestre-Bach G, Potenza MN. Mestre-Bach G, et al. CNS Drugs. 2024 Apr;38(4):255-265. doi: 10.1007/s40263-024-01075-2. Epub 2024 Mar 14. CNS Drugs. 2024. PMID: 38485889 Review. - Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis.
Palpacuer C, Hammas K, Duprez R, Laviolle B, Ioannidis JPA, Naudet F. Palpacuer C, et al. BMC Med. 2019 Sep 16;17(1):174. doi: 10.1186/s12916-019-1409-3. BMC Med. 2019. PMID: 31526369 Free PMC article. - Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
Park TW, Friedmann PD. Park TW, et al. R I Med J (2013). 2014 Oct 1;97(10):20-4. R I Med J (2013). 2014. PMID: 25271655 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical